AIHTA - Publications - Search - Covid-19: HSS/ Horizon Scanning Living Document

Wild, C and Wolf, S and Goetz, G and Walter, M and McEntee, J and Stanak, M and Ettinger, S and Strohmaier, C and Erdos, J and Huic, M. (2020): Covid-19: HSS/ Horizon Scanning Living Document. AIHTA Policy Brief 002.

[img]PDF (Covid-19: Horizon Scanning Living Document (v01_April 2020)_Teil/Part 1) - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
1158Kb
[img]PDF (Covid-19: Horizon Scanning Living Document (v01_April 2020), Teil/Part 2: Appendix) - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
7Mb
[img]PDF (Covid-19: HSS/ Horizon Scanning Living Document (v02 Mai 2020)) - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
17Mb
[img]PDF (Covid-19: Horizon Scanning Living Document (v02_Mai 2020), Teil/Part 2: Appendix) - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
879Kb
Abstract

On March 30th 2020, a request was raised by the Austrian Ministry of Health (BMASGK) and further Austrian policy stakeholder to set up a Horizon Scanning System (HSS) for medicines and vaccines. The establishment of a HSS/ Horizon Scanning System for Covid-19 interventions has the intentions of

a. informing health policy makers at an early stage which interventions (vaccinations and drugs) are currently undergoing clinical trials and

b. monitoring them over the next few months in order to support evidence-based purchasing, if necessary.

To respond to this request,

1. As a first step an inventory, based on international sources, is built.
2. As a second step, selective searches by means of searches in study registries are carried out for information on clinical studies in humans and the state of research.
3. This information forms the basis for "vignettes" (short descriptions) for those products that are already at an "advanced" stage.
4. Subsequently, the products are monitored with regard to the status of the clinical studies up to approval and finally evaluated for their benefit and harm.
All work steps are conducted in close international (European) cooperation.

Item Type:Rapid Assessment LBI-HTA
Keywords:Covid-19, coronavirus, pandemic, vaccine, medicine, drugs
Subjects:WA Public health > WA 525-590 Health administration and organisation
WB Practice of medicine > WB 300-962 Therapeutics
WA Public health > WA 108-245 Preventive medicine
WB Practice of medicine > WB 102 Evidence-based medicine
WF Respiratory system
QW Microbiology. Immunology > QW 501-949 Immunology
QV Pharmacology, toxicology, pharmacy > QV 701-737 Pharmacy
QV Pharmacology, toxicology, pharmacy > QV 247-269 Anti-inflammatory agents. Anti-infective agents
WB Practice of medicine > WB 340-356 Drug Administration
WC Communicable diseases
QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
WA Public health > WA 105 Epidemiology
Language:English
Series Name:AIHTA Policy Brief 002
Deposited on:14 Apr 2020 03:26
Last Modified:15 May 2020 14:17

Repository Staff Only: item control page